4.6 Article

Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Natural Steroidal Lactone Induces G1/S Phase Cell Cycle Arrest and Intrinsic Apoptotic Pathway by Up-Regulating Tumor Suppressive miRNA in Triple-Negative Breast Cancer Cells

Mohd Shuaib et al.

Summary: In this study, it was found that Withaferin A (WA) can exert an anticancer effect on triple-negative breast cancer cells by modulating the expression of miRNA. The results showed that WA up-regulated the expression of miR-181c-5p and down-regulated the expression of miR-1275, among other miRNAs. These miRNAs were found to affect the expression of cancer-associated genes and signaling pathways. Additionally, co-treatment of WA and miR-181c-5p mimic inhibited cell growth, induced apoptosis, and regulated the expression of genes involved in cell cycle and apoptosis.

METABOLITES (2023)

Article Biochemistry & Molecular Biology

Identification of miRNAs and related hub genes associated with the triple negative breast cancer using integrated bioinformatics analysis and in vitro approach

Mohd Shuaib et al.

Summary: The study identified DEMs and hub genes in TNBC microarray data, validated in a cell model, and investigated the effect of anticancer phytochemicals on gene expression. Furthermore, the association of specific miRNAs and hub genes with TNBC tumorigenesis and patient survival was highlighted, suggesting their potential as therapeutic targets.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Biochemistry & Molecular Biology

Withaferin A mediated changes of miRNA expression in breast cancer-derived mammospheres

Kumari Sunita Prajapati et al.

Summary: Breast cancer is a heterogeneous disease, and WA inhibits the proliferation and stemness of breast cancer cells by modulating miRNA expression, thereby inhibiting mammosphere formation.

MOLECULAR CARCINOGENESIS (2022)

Review Biochemistry & Molecular Biology

MicroRNA Regulation of Breast Cancer Stemness

Brock Humphries et al.

Summary: Recent advances in understanding breast cancer have highlighted the key role of CSCs in progression and recurrence, with miRNAs playing a crucial role in regulating CSC characteristics. MiRNAs have the potential to serve as biomarkers and clinical therapeutics for breast cancer by targeting signaling pathways associated with CSCs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

miRNA-Based Therapeutics in Breast Cancer: A Systematic Review

Anna Maria Grimaldi et al.

Summary: The systematic review on miRNA-based therapeutics for breast cancer revealed that miR-21, miR-34a, and miR-205a are potential anti-tumor and anti-metastatic molecules in in vivo experiments, especially in the treatment of triple-negative breast cancer.

FRONTIERS IN ONCOLOGY (2021)

Article Biotechnology & Applied Microbiology

Identification of cancer stemness related miRNA(s) using integrated bioinformatics analysis and in vitro validation

Kumari Sunita Prajapati et al.

Summary: This study identified 22 common miRNAs involved in regulating major stem cell signaling pathways, including miRNAs associated with breast cancer stemness. The clinical relevance of these miRNAs was confirmed by survival analysis in breast cancer patients, showing poor overall survival and high expression levels in invasive breast cancer subgroups. Further validation in in vitro models demonstrated the downregulation of lead miRNA with phytochemical treatment.

3 BIOTECH (2021)

Review Cell Biology

Role of STAT3 signaling pathway in breast cancer

Jia-hui Ma et al.

CELL COMMUNICATION AND SIGNALING (2020)

Review Biochemistry & Molecular Biology

Targeting cancer stem cell pathways for cancer therapy

Liqun Yang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Oncology

The biology and role of CD44 in cancer progression: therapeutic implications

Chen Chen et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Article Multidisciplinary Sciences

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer

Meiou Dai et al.

SCIENTIFIC REPORTS (2016)

Review Biochemistry & Molecular Biology

Harnessing the apoptotic programs in cancer stem-like cells

Ying-Hua Wang et al.

EMBO REPORTS (2015)

Review Pathology

The Role of Breast Cancer Stem Cells in Metastasis and Therapeutic Implications

Marco A. Velasco-Velazquez et al.

AMERICAN JOURNAL OF PATHOLOGY (2011)

Article Biochemistry & Molecular Biology

Direct reprogramming of stem cell properties in colon cancer cells by CD44

Ying-Jhen Su et al.

EMBO JOURNAL (2011)

Article Medicine, Research & Experimental

The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors

Lauren L. C. Marotta et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Review Oncology

Understanding the Dual Nature of CD44 in Breast Cancer Progression

Jeanne M. V. Louderbough et al.

MOLECULAR CANCER RESEARCH (2011)